Pharming: good news?




By




Pharmaceuticals rose 1% to 1.08 euro on Tuesday, when the company announced that it had recruited the first pediatric patient (4 to 11 years old) in the phase III study which is evaluating leniolisib in patients with APDS. This open-label, single-arm study will be conducted across sites in the US,…

This stock market news is for subscribers only Privileges


Test our stock market advice for €1, without obligation


I subscribe

Already subscribed? Login

Discover Boursier.com services Privileges


  • 8:30 am
    Recognition of the day

  • 4 to 5 stock tips per day


    4 to 5 tips
    scholarship holders per day

  • weekly newsletter


    Weekly Newsletter “Opportunities”



  • Wallets
    defensive, balanced
    and dynamic


Learn more


©2023 Boursier.com



Source link -87